GlassScriptPhysician profile
Rebecca D Eirich
NPI 1003001678
$1,903.88
in general payments reported to CMS, 2019-2025
20 companies · $535 in 2025
The $535 reported for 2025 was more than what 85% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $285 · 2023: $499 · 2024: $585 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,493 · Education: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,493.06 |
| Education | $125.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $350.82 | 2022-2025 | |
| Shield Therapeutics INC | $283.22 | 2023-2025 | Accrufer |
| Astellas Pharma US INC | $274.23 | 2022-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $124.22 | 2022-2025 | Phexxi, Solosec, Phexx |
| Sumitomo Pharma America, INC. | $102.07 | 2023-2024 | Myfembree, Gemtesa |
| Millicent US INC | $95.72 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Hologic Sales and Service, LLC | $88.86 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Exact Sciences Corporation | $84.95 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Sage Therapeutics, LLC | $84.57 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $75.43 | 2024-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $63.22 | 2023-2025 | |
| Urovant Sciences INC | $59.32 | 2022 | |
| Mayne Pharma Commercial LLC | $36.51 | 2022-2025 | |
| Coopersurgical, INC. | $36.47 | 2023 | Endosee |
| Organon LLC | $35.53 | 2022-2025 | Nexplanon |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $26.78 | 2023-2024 | |
| Mylan Pharmaceuticals INC. | $26.43 | 2022 | |
| Convatec INC. | $23.86 | 2024 | |
| Acella Pharmaceuticals, LLC | $16.00 | 2025 | NP Thyroid 60 |
| Myovant Sciences INC. | $15.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Eirich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.